COVID-19 mortality for cancer patients is driven by age, gender and comorbidities but not by whether they are on cytotoxic chemotherapy or other anticancer treatments, a recent study suggests.

Researchers from the UK drew their data from a network of 55 cancer centres with a patient population of nearly 1.5 million people with active cancer.